Stifel Nicolaus reaffirmed their buy rating on shares of Masimo Corporation (NASDAQ:MASI) in a report published on Friday morning. The firm currently has a $108.00 price objective on the medical equipment provider’s stock.

A number of other equities analysts have also weighed in on MASI. BidaskClub lowered shares of Masimo Corporation from a hold rating to a sell rating in a research report on Wednesday, August 9th. BTIG Research upgraded shares of Masimo Corporation from a neutral rating to a buy rating and set a $100.00 target price for the company in a research report on Monday, August 14th. Zacks Investment Research upgraded shares of Masimo Corporation from a hold rating to a buy rating and set a $98.00 target price for the company in a research report on Thursday. Finally, Roth Capital upped their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a buy rating in a research report on Wednesday, July 19th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus target price of $97.17.

Shares of Masimo Corporation (MASI) traded up $1.51 during trading hours on Friday, hitting $86.00. 333,270 shares of the company were exchanged, compared to its average volume of 384,306. The stock has a market cap of $4,443.71, a P/E ratio of 32.95, a price-to-earnings-growth ratio of 2.90 and a beta of 0.75.

Masimo Corporation (NASDAQ:MASI) last issued its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.17. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. The firm had revenue of $193.69 million during the quarter, compared to analyst estimates of $189.01 million. During the same quarter in the prior year, the business earned $0.52 earnings per share. Masimo Corporation’s revenue for the quarter was up 15.6% on a year-over-year basis. equities analysts forecast that Masimo Corporation will post 2.96 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Masimo Corporation (MASI) Given “Buy” Rating at Stifel Nicolaus” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/masimo-corporation-masi-given-buy-rating-at-stifel-nicolaus/1681524.html.

In other news, EVP Yongsam Lee sold 5,000 shares of the stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $89.89, for a total value of $449,450.00. Following the sale, the executive vice president now owns 74,000 shares of the company’s stock, valued at $6,651,860. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Sanford Fitch sold 11,000 shares of the stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total transaction of $959,750.00. Following the completion of the sale, the director now directly owns 72,249 shares in the company, valued at approximately $6,303,725.25. The disclosure for this sale can be found here. In the last three months, insiders sold 26,000 shares of company stock worth $2,309,200. Insiders own 16.60% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Alps Advisors Inc. raised its stake in shares of Masimo Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 4,997 shares of the medical equipment provider’s stock valued at $456,000 after acquiring an additional 13 shares during the period. Sterling Capital Management LLC raised its stake in shares of Masimo Corporation by 0.6% in the second quarter. Sterling Capital Management LLC now owns 7,803 shares of the medical equipment provider’s stock valued at $711,000 after acquiring an additional 44 shares during the period. Ifrah Financial Services Inc. raised its stake in shares of Masimo Corporation by 1.2% in the second quarter. Ifrah Financial Services Inc. now owns 4,564 shares of the medical equipment provider’s stock valued at $416,000 after acquiring an additional 53 shares during the period. Hanseatic Management Services Inc. raised its stake in shares of Masimo Corporation by 1.1% in the second quarter. Hanseatic Management Services Inc. now owns 5,273 shares of the medical equipment provider’s stock valued at $481,000 after acquiring an additional 58 shares during the period. Finally, Dubuque Bank & Trust Co. raised its stake in shares of Masimo Corporation by 3.4% in the second quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after acquiring an additional 61 shares during the period. 82.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Analyst Recommendations for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.